Clinical Trials in New York

Showing 11401-11420 of 22,668 trials

Reducing the Duration of Untreated Psychosis in the United States

NCT03369730

The goal of this project is to investigate whether a systematic screening approach for individuals with first episode psychosis (FEP) can substantially reduce Duration of Untreated Psychosis (DUP). The study team will evaluate the feasibility of screening a consecutive help-seeking population entering mental health services in order to facilitate early identification of FEP cases, rapid referral to specialty care and engagement in treatment.

First Episode Psychosis (FEP)At Risk Mental State (ARMS)

Icahn School of Medicine at Mount Sinai94 participantsStarted Feb 2018

Boston, Massachusetts, United States • New York, New York, United States • New York, New York, United States

COMPLETED< 1 mile

Restore EF Observational Study

NCT04648306

A multi-center, prospective, observational, non-interventional single arm, study of the intermediate-term clinical outcomes collected from electronic health records of high-risk patients which have previously undergone standard of care prophylactic Impella support for a non-emergent percutaneous coronary intervention (PCI).

Coronary Artery DiseaseUnstable AnginaAngina, Stable+1 more

Abiomed Inc.406 participantsStarted Sep 2019

Phoenix, Arizona, United States • Tucson, Arizona, United States • Fayetteville, Arkansas, United States +18 more locations

Reducing the Duration of Untreated Psychosis in the United States

Restore EF Observational Study

Find Trials by Condition in New York

Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in CVD

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)

Evaluation of PerioMonitor for Detection of Oral Inflammatory Load (OIL) in Human Subjects

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning

Assessment of LBR-101 In Chronic Migraine

Montefiore Medical Center Healthy Marriage and Relationship Education Program

Biological Effects of Ultrasound Insonification of the Spleen

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

Study of INCB053914 in Subjects With Advanced Malignancies

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)

An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

PREMOD2 With Near Infrared Spectroscopy Sub-study